Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 38

1.

The C-Type Lectin Receptor DC-SIGN Has an Anti-Inflammatory Role in Human M(IL-4) Macrophages in Response to Mycobacterium tuberculosis.

Lugo-Villarino G, Troegeler A, Balboa L, Lastrucci C, Duval C, Mercier I, Bénard A, Capilla F, Al Saati T, Poincloux R, Kondova I, Verreck FAW, Cougoule C, Maridonneau-Parini I, Sasiain MDC, Neyrolles O.

Front Immunol. 2018 Jun 12;9:1123. doi: 10.3389/fimmu.2018.01123. eCollection 2018.

2.

Toward Tuberculosis Vaccine Development: Recommendations for Nonhuman Primate Study Design.

Laddy DJ, Bonavia A, Hanekom WA, Kaushal D, Williams A, Roederer M, Seder RA, Sharpe S, Verreck FAW, Darrah PA.

Infect Immun. 2018 Jan 22;86(2). pii: e00776-17. doi: 10.1128/IAI.00776-17. Print 2018 Feb.

3.

TBVAC2020: Advancing Tuberculosis Vaccines from Discovery to Clinical Development.

Kaufmann SHE, Dockrell HM, Drager N, Ho MM, McShane H, Neyrolles O, Ottenhoff THM, Patel B, Roordink D, Spertini F, Stenger S, Thole J, Verreck FAW, Williams A; TBVAC2020 Consortium.

Front Immunol. 2017 Oct 4;8:1203. doi: 10.3389/fimmu.2017.01203. eCollection 2017. Review.

4.

Variable BCG efficacy in rhesus populations: Pulmonary BCG provides protection where standard intra-dermal vaccination fails.

Verreck FAW, Tchilian EZ, Vervenne RAW, Sombroek CC, Kondova I, Eissen OA, Sommandas V, van der Werff NM, Verschoor E, Braskamp G, Bakker J, Langermans JAM, Heidt PJ, Ottenhoff THM, van Kralingen KW, Thomas AW, Beverley PCL, Kocken CHM.

Tuberculosis (Edinb). 2017 May;104:46-57. doi: 10.1016/j.tube.2017.02.003. Epub 2017 Feb 20.

5.

C-type lectin receptor DCIR modulates immunity to tuberculosis by sustaining type I interferon signaling in dendritic cells.

Troegeler A, Mercier I, Cougoule C, Pietretti D, Colom A, Duval C, Vu Manh TP, Capilla F, Poincloux R, Pingris K, Nigou J, Rademann J, Dalod M, Verreck FA, Al Saati T, Lugo-Villarino G, Lepenies B, Hudrisier D, Neyrolles O.

Proc Natl Acad Sci U S A. 2017 Jan 24;114(4):E540-E549. doi: 10.1073/pnas.1613254114. Epub 2017 Jan 9.

6.

Tuberculosis is associated with expansion of a motile, permissive and immunomodulatory CD16(+) monocyte population via the IL-10/STAT3 axis.

Lastrucci C, Bénard A, Balboa L, Pingris K, Souriant S, Poincloux R, Al Saati T, Rasolofo V, González-Montaner P, Inwentarz S, Moraña EJ, Kondova I, Verreck FA, Sasiain Mdel C, Neyrolles O, Maridonneau-Parini I, Lugo-Villarino G, Cougoule C.

Cell Res. 2015 Dec;25(12):1333-51. doi: 10.1038/cr.2015.123. Epub 2015 Oct 20.

7.

The translational value of non-human primates in preclinical research on infection and immunopathology.

't Hart BA, Bogers WM, Haanstra KG, Verreck FA, Kocken CH.

Eur J Pharmacol. 2015 Jul 15;759:69-83. doi: 10.1016/j.ejphar.2015.03.023. Epub 2015 Mar 23. Review.

PMID:
25814254
8.

Acute-phase responses in healthy and diseased rhesus macaques (Macaca mulatta).

Krogh AK, Lundsgaard JF, Bakker J, Langermans JA, Verreck FA, Kjelgaard-Hansen M, Jacobsen S, Bertelsen MF.

J Zoo Wildl Med. 2014 Jun;45(2):306-14.

PMID:
25000691
9.

Creativity in tuberculosis research and discovery.

Younga D, Verreck FA.

Tuberculosis (Edinb). 2012 Mar;92 Suppl 1:S14-6. doi: 10.1016/S1472-9792(12)70006-9. Review.

PMID:
22441152
10.

Rhesus macaques (Macaca mulatta) are natural hosts of specific Staphylococcus aureus lineages.

van den Berg S, van Wamel WJ, Snijders SV, Ouwerling B, de Vogel CP, Boelens HA, Willems RJ, Huijsdens XW, Verreck FA, Kondova I, Heidt PJ, Verbrugh HA, van Belkum A.

PLoS One. 2011;6(10):e26170. doi: 10.1371/journal.pone.0026170. Epub 2011 Oct 20. Erratum in: PLoS One. 2012;7(8). doi: 10.1371/annotation/bc0581bd-5ef5-4116-b3b6-6fc6c5eb197c.

11.

AIDS-protective HLA-B*27/B*57 and chimpanzee MHC class I molecules target analogous conserved areas of HIV-1/SIVcpz.

de Groot NG, Heijmans CM, Zoet YM, de Ru AH, Verreck FA, van Veelen PA, Drijfhout JW, Doxiadis GG, Remarque EJ, Doxiadis II, van Rood JJ, Koning F, Bontrop RE.

Proc Natl Acad Sci U S A. 2010 Aug 24;107(34):15175-80. doi: 10.1073/pnas.1009136107. Epub 2010 Aug 9.

12.

MVA.85A boosting of BCG and an attenuated, phoP deficient M. tuberculosis vaccine both show protective efficacy against tuberculosis in rhesus macaques.

Verreck FA, Vervenne RA, Kondova I, van Kralingen KW, Remarque EJ, Braskamp G, van der Werff NM, Kersbergen A, Ottenhoff TH, Heidt PJ, Gilbert SC, Gicquel B, Hill AV, Martin C, McShane H, Thomas AW.

PLoS One. 2009;4(4):e5264. doi: 10.1371/journal.pone.0005264. Epub 2009 Apr 15. Erratum in: PLoS One. 2011;6(2). doi:10.1371/annotation/e599dafd-8208-4655-a792-21cb125f7f66.

13.

Two patients with complete defects in interferon gamma receptor-dependent signaling.

Noordzij JG, Hartwig NG, Verreck FA, De Bruin-Versteeg S, De Boer T, Van Dissel JT, De Groot R, Ottenhoff TH, Van Dongen JJ.

J Clin Immunol. 2007 Sep;27(5):490-6. Epub 2007 May 21.

PMID:
17514500
14.

Radiation modulates the peptide repertoire, enhances MHC class I expression, and induces successful antitumor immunotherapy.

Reits EA, Hodge JW, Herberts CA, Groothuis TA, Chakraborty M, Wansley EK, Camphausen K, Luiten RM, de Ru AH, Neijssen J, Griekspoor A, Mesman E, Verreck FA, Spits H, Schlom J, van Veelen P, Neefjes JJ.

J Exp Med. 2006 May 15;203(5):1259-71. Epub 2006 Apr 24.

15.

Divergent effects of IL-12 and IL-23 on the production of IL-17 by human T cells.

Hoeve MA, Savage ND, de Boer T, Langenberg DM, de Waal Malefyt R, Ottenhoff TH, Verreck FA.

Eur J Immunol. 2006 Mar;36(3):661-70.

16.

Phenotypic and functional profiling of human proinflammatory type-1 and anti-inflammatory type-2 macrophages in response to microbial antigens and IFN-gamma- and CD40L-mediated costimulation.

Verreck FA, de Boer T, Langenberg DM, van der Zanden L, Ottenhoff TH.

J Leukoc Biol. 2006 Feb;79(2):285-93. Epub 2005 Dec 5.

PMID:
16330536
17.

Impact of peptides on the recognition of HLA class I molecules by human HLA antibodies.

Mulder A, Eijsink C, Kester MG, Franke ME, Kardol MJ, Heemskerk MH, van Kooten C, Verreck FA, Drijfhout JW, Koning F, Doxiadis II, Claas FH.

J Immunol. 2005 Nov 1;175(9):5950-7.

18.

Control of human host immunity to mycobacteria.

Ottenhoff TH, Verreck FA, Hoeve MA, van de Vosse E.

Tuberculosis (Edinb). 2005 Jan-Mar;85(1-2):53-64. Epub 2004 Dec 31. Review. Erratum in: Tuberculosis (Edinb). 2006 Jan;86(1):74-5.

PMID:
15687028
19.

Epstein-Barr virus gp42 is posttranslationally modified to produce soluble gp42 that mediates HLA class II immune evasion.

Ressing ME, van Leeuwen D, Verreck FA, Keating S, Gomez R, Franken KL, Ottenhoff TH, Spriggs M, Schumacher TN, Hutt-Fletcher LM, Rowe M, Wiertz EJ.

J Virol. 2005 Jan;79(2):841-52.

20.

3-D Structure of multilaminar lysosomes in antigen presenting cells reveals trapping of MHC II on the internal membranes.

Murk JL, Lebbink MN, Humbel BM, Geerts WJ, Griffith JM, Langenberg DM, Verreck FA, Verkleij AJ, Koster AJ, Geuze HJ, Kleijmeer MJ.

Traffic. 2004 Dec;5(12):936-45.

21.

Dissection of the HLA-DR4 peptide repertoire in endocrine epithelial cells: strong influence of invariant chain and HLA-DM expression on the nature of ligands.

Muntasell A, Carrascal M, Alvarez I, Serradell L, van Veelen P, Verreck FA, Koning F, Abian J, Jaraquemada D.

J Immunol. 2004 Jul 15;173(2):1085-93.

22.

Human IL-23-producing type 1 macrophages promote but IL-10-producing type 2 macrophages subvert immunity to (myco)bacteria.

Verreck FA, de Boer T, Langenberg DM, Hoeve MA, Kramer M, Vaisberg E, Kastelein R, Kolk A, de Waal-Malefyt R, Ottenhoff TH.

Proc Natl Acad Sci U S A. 2004 Mar 30;101(13):4560-5. Epub 2004 Mar 19.

23.

IL-12 receptor deficiency revisited: IL-23-mediated signaling is also impaired in human genetic IL-12 receptor beta1 deficiency.

Hoeve MA, de Boer T, Langenberg DM, Sanal O, Verreck FA, Ottenhoff TH.

Eur J Immunol. 2003 Dec;33(12):3393-7.

24.

Interference with T cell receptor-HLA-DR interactions by Epstein-Barr virus gp42 results in reduced T helper cell recognition.

Ressing ME, van Leeuwen D, Verreck FA, Gomez R, Heemskerk B, Toebes M, Mullen MM, Jardetzky TS, Longnecker R, Schilham MW, Ottenhoff TH, Neefjes J, Schumacher TN, Hutt-Fletcher LM, Wiertz EJ.

Proc Natl Acad Sci U S A. 2003 Sep 30;100(20):11583-8. Epub 2003 Sep 22.

25.

Human deficiencies in type-1 cytokine receptors reveal the essential role of type-1 cytokines in immunity to intracellular bacteria.

Ottenhoff TH, De Boer T, van Dissel JT, Verreck FA.

Adv Exp Med Biol. 2003;531:279-94. Review.

PMID:
12916800
26.

Severe Mycobacterium bovis BCG infections in a large series of novel IL-12 receptor beta1 deficient patients and evidence for the existence of partial IL-12 receptor beta1 deficiency.

Lichtenauer-Kaligis EG, de Boer T, Verreck FA, van Voorden S, Hoeve MA, van de Vosse E, Ersoy F, Tezcan I, van Dissel JT, Sanal O, Ottenhoff TH.

Eur J Immunol. 2003 Jan;33(1):59-69.

27.

Genetics, cytokines and human infectious disease: lessons from weakly pathogenic mycobacteria and salmonellae.

Ottenhoff TH, Verreck FA, Lichtenauer-Kaligis EG, Hoeve MA, Sanal O, van Dissel JT.

Nat Genet. 2002 Sep;32(1):97-105. Review. Erratum in: Nat Genet 2002 Oct;32(2):331.

PMID:
12205477
28.

Human host defense and cytokines in mycobacterial infectious diseases: interleukin-18 cannot compensate for genetic defects in the interleukin-12 system.

Verreck FA, de Boer T, Hoeve M, van Dissel JT, Sanal O, Kurimoto M, Ottenhoff TH.

Clin Infect Dis. 2002 Jul 15;35(2):210-2. No abstract available.

PMID:
12087531
29.

Setting a course for intervening in host-pathogen interactions.

Verreck FA, de Vries RR, Ottenhoff TH.

Trends Immunol. 2001 Nov;22(11):588-90.

PMID:
11698199
30.

Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM.

Verreck FA, Fargeas CA, Hämmerling GJ.

Eur J Immunol. 2001 Apr;31(4):1029-36.

31.

Human deficiencies in type 1 cytokine receptors reveal the essential role of type 1 cytokines in immunity to intracellular bacteria.

Ottenhoff TH, de Boer T, Verhagen CE, Verreck FA, van Dissel JT.

Microbes Infect. 2000 Nov;2(13):1559-66. Review.

PMID:
11113375
32.

Residual type 1 immunity in patients genetically deficient for interleukin 12 receptor beta1 (IL-12Rbeta1): evidence for an IL-12Rbeta1-independent pathway of IL-12 responsiveness in human T cells.

Verhagen CE, de Boer T, Smits HH, Verreck FA, Wierenga EA, Kurimoto M, Lammas DA, Kumararatne DS, Sanal O, Kroon FP, van Dissel JT, Sinigaglia F, Ottenhoff TH.

J Exp Med. 2000 Aug 21;192(4):517-28.

33.

Cryptic open reading frames in plasmid vector backbone sequences can provide highly immunogenic cytotoxic T-lymphocyte epitopes.

van Hall T, van de Rhee NE, Schoenberger SP, Vierboom MP, Verreck FA, Melief CJ, Offringa R.

Cancer Res. 1998 Jul 15;58(14):3087-93.

34.

The generation of SDS-stable HLA DR dimers is independent of efficient peptide binding.

Verreck FA, Vermeulen C, Poel AV, Jorritsma P, Amons R, Coligan JE, Drijfhout JW, Koning F.

Int Immunol. 1996 Mar;8(3):397-404.

PMID:
8671626
35.

Natural peptides isolated from Gly86/Val86-containing variants of HLA-DR1, -DR11, -DR13, and -DR52.

Verreck FA, van de Poel A, Drijfhout JW, Amons R, Coligan JE, Konig F.

Immunogenetics. 1996;43(6):392-7. No abstract available.

PMID:
8606061
36.

DR4Dw4/DR53 molecules contain a peptide from the autoantigen calreticulin.

Verreck FA, Elferink D, Vermeulen CJ, Amons R, Breedveld F, de Vries RR, Koning F.

Tissue Antigens. 1995 Apr;45(4):270-5.

PMID:
7638864
37.

Identification of an HLA-DQ2 peptide binding motif and HLA-DPw3-bound self-peptide by pool sequencing.

Verreck FA, van de Poel A, Termijtelen A, Amons R, Drijfhout JW, Koning F.

Eur J Immunol. 1994 Feb;24(2):375-9.

PMID:
8299686
38.

HLA-DR beta chain residue 86 controls DR alpha beta dimer stability.

Verreck FA, Termijtelen A, Koning F.

Eur J Immunol. 1993 Jun;23(6):1346-50.

PMID:
8500529

Supplemental Content

Loading ...
Support Center